{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:43:45Z","timestamp":1790545425237,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jsbmb.2006.12.094","type":"journal-article","created":{"date-parts":[[2006,12,26]],"date-time":"2006-12-26T09:08:13Z","timestamp":1167124093000},"page":"546-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta"],"prefix":"10.1016","volume":"103","author":[{"given":"Evelyne","family":"van Etten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny","family":"Gysemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumitru D.","family":"Branisteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Verstuyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lut","family":"Overbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2006.12.094_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","article-title":"The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents","volume":"8","author":"Mathieu","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts","volume":"97","author":"van Etten","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.10329","article-title":"Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators","volume":"88","author":"van Etten","year":"2003","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib4","doi-asserted-by":"crossref","first-page":"IV3","DOI":"10.1007\/s00415-003-1402-8","article-title":"Lessons from 10 years of interferon beta-1b (Betaferon\/Betaseron) treatment","volume":"250","author":"Bayas","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1212\/WNL.51.3.682","article-title":"Interferon beta in the treatment of multiple sclerosis: mechanisms of action","volume":"51","author":"Yong","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","article-title":"Interferons alpha and beta as immune regulators\u2014a new look","volume":"14","author":"Biron","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-5728(89)90072-6","article-title":"Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes","volume":"23","author":"Barna","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(93)90244-S","article-title":"Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis","volume":"46","author":"Noronha","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib9","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/WNL.52.9.1764","article-title":"Interferon beta-1b treatment modulates TNFalpha and IFNgamma spontaneous gene expression in MS","volume":"52","author":"Gayo","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-5728(98)00139-8","article-title":"Cytokine gene expression in cells derived from CSF of multiple sclerosis patients","volume":"89","author":"Calabresi","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.49.4.1111","article-title":"VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta","volume":"49","author":"Calabresi","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib12","first-page":"1015","article-title":"Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer","volume":"79","author":"Lou","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2249.2002.01825.x","article-title":"Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3","volume":"128","author":"Gysemans","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib14","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/00007890-200005150-00032","article-title":"Analogs of 1,25-dihyhdroxyvitamin D3 as dose reducing agents for classical immunosuppressants","volume":"69","author":"van Etten","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S8756-3282(03)00030-9","article-title":"Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone","volume":"32","author":"van Etten","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","article-title":"Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3","volume":"37","author":"Mathieu","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib17","doi-asserted-by":"crossref","unstructured":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFN-beta Multiple Sclerosis Study Group, Neurology 43 (1993) 655\u2013661.","DOI":"10.1212\/WNL.43.4.655"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib19","first-page":"96","article-title":"Treatment of multiple sclerosis with human beta interferon","volume":"12","author":"Goodin","year":"2005","journal-title":"Int. MS J."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-5728(95)00160-3","article-title":"Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis","volume":"64","author":"Yu","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2249.2000.01175.x","article-title":"Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment","volume":"120","author":"Ozenci","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","article-title":"1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis","volume":"87","author":"Lemire","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib23","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1210\/endo.135.6.7988477","article-title":"1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo","volume":"135","author":"Lemire","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-5728(95)00076-E","article-title":"Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha,25-(OH)2D3","volume":"61","author":"Branisteanu","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-5728(97)00116-1","article-title":"Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo","volume":"79","author":"Branisteanu","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","article-title":"Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3","volume":"30","author":"Mattner","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis","volume":"216","author":"Hayes","year":"1997","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib28","first-page":"230","article-title":"Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?","volume":"223","author":"Cantorna","year":"2000","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib29","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.ejcn.1601952","article-title":"Multiple sclerosis and vitamin D: an update","volume":"58","author":"Van Amerongen","year":"2004","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib30","series-title":"Vitamin D","first-page":"33","article-title":"Photobiology of vitamin D","author":"Holick","year":"1997"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(99)00198-8","article-title":"IFN-beta modulates specific T cell responses in vitro but does not affect experimental autoimmune encephalomyelitis in the SJL mouse","volume":"100","author":"Luca","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0090-1229(86)90027-9","article-title":"Cyclosporin A treatment of an induced attack in a chronic relapsing model of experimental allergic encephalomyelitis","volume":"40","author":"Schuller-Levis","year":"1986","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-5728(99)00047-8","article-title":"Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein","volume":"97","author":"McCombe","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2006.12.094_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jnnp.52.5.559","article-title":"Randomised double blind controlled trial of cyclosporin in multiple sclerosis","volume":"52","author":"Rudge","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib35","doi-asserted-by":"crossref","unstructured":"Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group, Ann. Neurol. 27 (1990) 591\u2013605.","DOI":"10.1002\/ana.410270603"},{"key":"10.1016\/j.jsbmb.2006.12.094_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol. Today"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076006004602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076006004602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:53:05Z","timestamp":1760734385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076006004602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":36,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0960076006004602"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2006.12.094","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2006.12.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}